2020
DOI: 10.1007/s00464-020-07367-0
|View full text |Cite
|
Sign up to set email alerts
|

Does three-dimensional surgery affect recurrence patterns in patients with gastric cancer after laparoscopic R0 gastrectomy? Results from a 3-year follow-up phase III trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…After the matching under propensity scores, there was no significant difference in the overall survival rate of patients in the 2 years after surgery between the experimental group and the control group ( P > 0.05). The existing researches pointed out no statistically significant difference in the long-term efficacies of advanced gastric cancer with laparoscopic surgery and traditional open surgery [ 24 ]. It was concluded that the Da Vinci robotic surgery system was the same as laparoscopic surgery in terms of radical resection of distal gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…After the matching under propensity scores, there was no significant difference in the overall survival rate of patients in the 2 years after surgery between the experimental group and the control group ( P > 0.05). The existing researches pointed out no statistically significant difference in the long-term efficacies of advanced gastric cancer with laparoscopic surgery and traditional open surgery [ 24 ]. It was concluded that the Da Vinci robotic surgery system was the same as laparoscopic surgery in terms of radical resection of distal gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…The CLASS-04 trial (ClinicalTrials.gov, NCT02845986) enrolled 251 patients between September, 2016 and October, 2017 to evaluate the safety and feasibility of LSPSHL for LAPGC, conducted at specialized institutions of the Chinese Laparoscopic Gastrointestinal Surgery Study group [9]. The FUGES-001 trial (ClinicalTrials.gov, NCT02327481) enrolled 438 patients between January, 2015 and April, 2016 to determine the efficiency of 3D LG and 2D LG in GC, conducted at Fujian Medical University Union Hospital (FMUUH) [29,30]. The FUGES-002 trial (Clinical-Trials.gov, NCT02333721) enrolled 536 patients between January, 2015 and December, 2018 to evaluate the surgical outcomes of LSPSHL for non-Gre-invading LAPGC, conducted at FMUUH.…”
Section: Participantsmentioning
confidence: 99%
“…Each of the four studies were approved by their institution's local ethics committee. Operative techniques, definitions of study endpoints, and results of these studies have been reported previously [9,[29][30][31]. Heterogeneity between the four trials was minimized by the use of the same laparoscopic surgery procedure.…”
Section: Participantsmentioning
confidence: 99%